The App NL-G-F mouse retina is a site for preclinical Alzheimer’s disease diagnosis and research
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The App NL-G-F mouse retina is a site for preclinical Alzheimer’s disease diagnosis and research ; volume:9 ; number:1 ; day:6 ; month:1 ; year:2021 ; pages:1-16 ; date:12.2021
Acta Neuropathologica Communications ; 9, Heft 1 (6.1.2021), 1-16, 12.2021
- Urheber
-
Vandenabeele, Marjan
Veys, Lien
Lemmens, Sophie
Hadoux, Xavier
Gelders, Géraldine
Masin, Luca
Serneels, Lutgarde
Theunis, Jan
Saito, Takashi
Saido, Takaomi C.
Jayapala, Murali
Boever, Patrick De
Strooper, Bart De
Stalmans, Ingeborg
Wijngaarden, Peter van
Moons, Lieve
Groef, Lies De
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-020-01102-5
- URN
-
urn:nbn:de:101:1-2021020802555669876715
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vandenabeele, Marjan
- Veys, Lien
- Lemmens, Sophie
- Hadoux, Xavier
- Gelders, Géraldine
- Masin, Luca
- Serneels, Lutgarde
- Theunis, Jan
- Saito, Takashi
- Saido, Takaomi C.
- Jayapala, Murali
- Boever, Patrick De
- Strooper, Bart De
- Stalmans, Ingeborg
- Wijngaarden, Peter van
- Moons, Lieve
- Groef, Lies De
- SpringerLink (Online service)
Ähnliche Objekte (12)
APP mouse models for Alzheimer's disease preclinical studies
Ocular indicators of Alzheimer’s: exploring disease in the retina
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
APOE effects on regional tau in preclinical Alzheimer’s disease
An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
Preclinical Alzheimer’s dementia: a useful concept or another dead end?
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease
Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2
APP mouse models for Alzheimer's disease preclinical studies
Ocular indicators of Alzheimer’s: exploring disease in the retina
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
APOE effects on regional tau in preclinical Alzheimer’s disease
An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
Preclinical Alzheimer’s dementia: a useful concept or another dead end?
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease
Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2
APP mouse models for Alzheimer's disease preclinical studies
Ocular indicators of Alzheimer’s: exploring disease in the retina
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
APOE effects on regional tau in preclinical Alzheimer’s disease
An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
Preclinical Alzheimer’s dementia: a useful concept or another dead end?
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease
Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina